[{"address1": "250 East Grand Avenue", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 338 3533", "website": "https://septerna.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. The company also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders, including obesity and type 2 diabetes. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeffrey T. Finer M.D., Ph.D.", "age": 57, "title": "Co-Founder, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 919071, "exercisedValue": 0, "unexercisedValue": 4407855}, {"maxAge": 1, "name": "Ms. Elizabeth P. Bhatt M.B.A., M.S.", "age": 56, "title": "President & COO", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 661829, "exercisedValue": 0, "unexercisedValue": 880593}, {"maxAge": 1, "name": "Dr. Jae B. Kim FACC, M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 486288, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert J. Lefkowitz M.D.", "age": 80, "title": "Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board", "yearBorn": 1944, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arthur  Christopoulos BPHARM, Ph.D.", "title": "Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrick  Sexton Ph.D.", "title": "Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gilbert M. Labrucherie C.F.A., J.D.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard  Hansen Ph.D.", "title": "Vice President of Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Xu Ph.D.", "title": "Senior Director of Corporate Development & Portfolio Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Samira  Shaikhly", "age": 54, "title": "Chief People Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 536487, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 27.54, "open": 28.54, "dayLow": 28.5, "dayHigh": 30.5, "regularMarketPreviousClose": 27.54, "regularMarketOpen": 28.54, "regularMarketDayLow": 28.5, "regularMarketDayHigh": 30.5, "payoutRatio": 0.0, "forwardPE": -82.464455, "volume": 841275, "regularMarketVolume": 841275, "averageVolume": 342495, "averageVolume10days": 343710, "averageDailyVolume10Day": 343710, "bid": 18.72, "ask": 32.8, "bidSize": 2, "askSize": 2, "marketCap": 1324420608, "fiftyTwoWeekLow": 4.17, "fiftyTwoWeekHigh": 30.5, "allTimeHigh": 30.5, "allTimeLow": 4.17, "priceToSalesTrailing12Months": 60.07805, "fiftyDayAverage": 23.6306, "twoHundredDayAverage": 13.92815, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 874184576, "profitMargins": -2.66768, "floatShares": 18749193, "sharesOutstanding": 44774192, "sharesShort": 1477425, "sharesShortPriorMonth": 2025667, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.033, "heldPercentInsiders": 0.031489998, "heldPercentInstitutions": 1.00782, "shortRatio": 4.19, "shortPercentOfFloat": 0.056799997, "impliedSharesOutstanding": 44774192, "bookValue": 8.708, "priceToBook": 3.3968763, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -58809000, "trailingEps": -6.9, "forwardEps": -0.3587, "enterpriseToRevenue": 39.655, "enterpriseToEbitda": -9.945, "52WeekChange": 0.091915846, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 29.58, "targetHighPrice": 38.0, "targetLowPrice": 25.0, "targetMeanPrice": 31.5, "targetMedianPrice": 32.0, "recommendationMean": 1.14286, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 474345984, "totalCashPerShare": 10.594, "ebitda": -87901000, "totalDebt": 24110000, "quickRatio": 6.457, "currentRatio": 6.531, "totalRevenue": 22045000, "debtToEquity": 6.202, "revenuePerShare": 0.534, "returnOnAssets": -0.14325, "returnOnEquity": -0.22383, "grossProfits": 22045000, "freeCashflow": -1729500, "operatingCashflow": 104219000, "revenueGrowth": 121.131, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -0.45992002, "financialCurrency": "USD", "symbol": "SEPN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 7.4074, "regularMarketPrice": 29.58, "corporateActions": [], "postMarketTime": 1766183963, "regularMarketTime": 1766178002, "exchange": "NGM", "messageBoardId": "finmb_1765584396", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1729863000000, "postMarketChangePercent": 0.0, "postMarketPrice": 29.58, "postMarketChange": 0.0, "regularMarketChange": 2.04, "regularMarketDayRange": "28.5 - 30.5", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 342495, "fiftyTwoWeekLowChange": 25.41, "fiftyTwoWeekLowChangePercent": 6.093525, "fiftyTwoWeekRange": "4.17 - 30.5", "fiftyDayAverageChange": 5.9494, "fiftyDayAverageChangePercent": 0.25176677, "twoHundredDayAverageChange": 15.65185, "twoHundredDayAverageChangePercent": 1.1237565, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-10-25", "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "fiftyTwoWeekHighChange": -0.9200001, "fiftyTwoWeekHighChangePercent": -0.030163936, "fiftyTwoWeekChangePercent": 9.191585, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -6.9, "epsForward": -0.3587, "epsCurrentYear": -0.93739, "priceEpsCurrentYear": -31.555702, "shortName": "Septerna, Inc.", "longName": "Septerna, Inc.", "displayName": "Septerna", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]